Histone H3.3 Mutations Drive Pediatric Glioblastoma through Upregulation of MYCN
Lynn Bjerke(Institute of Cancer Research), Chris Jones(North Carolina State University), Kathryn R. Taylor(Stanford University), Darren Hargrave(Great Ormond Street Hospital), Alexa Jury(Royal Veterinary College), Dorine A. Bax(Brain Tumour Research), Imelda M. McGonnell(Royal Veterinary College), Rui Manuel Reis(Hospital de Câncer de Barretos), Paul Workman(Institute of Cancer Research), Alan Ashworth(University of California, San Francisco), Anna Burford(Cancer Research Institute of the Slovak Academy of Sciences), Alan Mackay(Institute of Cancer Research), Diana Carvalho(Institute of Cancer Research), Meera Nandhabalan(Institute of Cancer Research), Christopher J. Lord(Institute of Cancer Research), Sergey Popov(Heidelberg University), Ilirjana Bajrami(Institute of Cancer Research), Maria Vinci(Cancer Research UK)
Cited by 320
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Guidelines for the welfare and use of animals in cancer research
|British Journal of Cancer|2010|1.4k